Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

* To determine whether LVOT VTI \< 15 cm predicts the development of in-hospital cardiogenic shock or need for vasopressors in STEMI patients undergoing primary PCI. * To assess association of LVOT VTI with other adverse outcomes (in-hospital death, heart failure, arrhythmias, need for mechanical ventilation, prolonged hospital stay).

Eligibility criteria

Qualifiers

Adult patients (≥18 years), diagnosed with acute STEMI according to current ESC guidelines(3) and undergoing primary PCI within 24 hours of symptom onset.

Patients undergo transthoracic echocardiography within 24 hours of admission.

Disqualifiers

Presence of significant aortic valve disease (e.g., severe aortic stenosis or regurgitation).

LVOT obstruction or hypertrophic cardiomyopathy.

Poor echocardiographic window.

Refusal to participate.

Trial design

Treatments tested in this trial

  • Echocardiography

Treatment groups

125 Participants
are divided into 2 treatment groups

Sponsors and collaborators